Arch Biopartners Inc.
ARCH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.61M | -2.88M | -1.89M | -1.58M | -1.44M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 604.50K | 1.13M | -158.50K | 584.70K | 122.70K |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -2.00M | -1.76M | -2.05M | -996.10K | -1.32M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -1.00M | -1.00M |
| Total Debt Issued | 908.00K | 446.20K | 1.91M | 1.60M | 3.05M |
| Total Debt Repaid | -216.60K | -245.10K | -1.10M | -1.10M | -1.10M |
| Issuance of Common Stock | 1.81M | 1.36M | 935.00K | 300.50K | 128.00K |
| Repurchase of Common Stock | -- | -- | -201.50K | -201.50K | -201.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -115.00K | 53.00K | 53.00K |
| Cash from Financing | 1.82M | 1.15M | 1.05M | 478.80K | 1.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -185.20K | -610.90K | -1.00M | -517.50K | 107.80K |